OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
413857

Dynamic Medical Technologies Inc

Medical Equipment, Supplies & DistributionVerified

Dynamic Medical Technologies Inc maintains a conservative capital structure, with a debt-to-equity ratio of 0.24, indicating limited leverage and a strong equity base. The company's liquidity position is characterized by a current ratio of 2.16, suggesting it has sufficient short-term assets to cover its liabilities. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) of 9.11% and return on assets (ROA) of 4.86% are below the industry median for medical equipment firms, which typically report ROE in the 12-15% range and ROA in the 6-8% range. This suggests that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in the Taiwan market, where it operates as a primary sales and service provider for medical beauty equipment. No significant international operations are disclosed, and the company does not report revenue by geographic segment beyond its domestic focus. This geographic concentration may expose the company to local economic and regulatory risks. The company's growth trajectory is modest, with no disclosed revenue growth rates or future projections in the provided data. The capital expenditure of -52.15 million TWD indicates a reduction in investment in physical assets, which may reflect a focus on cost control or a shift toward service-based offerings. The company's operating cash flow of 314.86 million TWD and free cash flow of 126.47 million TWD suggest it generates positive cash from operations, but the lack of growth capital spending may limit long-term expansion. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the absence of recent share issuance and the alignment of basic and diluted shares outstanding. However, the negative net cash position after debt is a red flag for liquidity risk, particularly if the company faces unexpected cash outflows. Recent events include the company's latest financial filing, which provides a snapshot of its financial position as of the latest reporting period. No recent earnings call transcripts or material events are disclosed in the input data, limiting visibility into management commentary or strategic shifts.

30-day price · 4138-10.00 (-16.1%)
Low$50.50High$65.80Close$52.10As of21 May, 00:00 UTC
Profile
CompanyDynamic Medical Technologies Inc
Ticker4138.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Dynamic Medical Technologies Inc is a Taiwan-based company engaged in the sales of medical beauty equipment, including laser and pulsed light devices, and provides related consumables, maintenance, and treatment services.

Classification. The company is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

Dynamic Medical Technologies Inc maintains a conservative capital structure, with a debt-to-equity ratio of 0.24, indicating limited leverage and a strong equity base. The company's liquidity position is characterized by a current ratio of 2.16, suggesting it has sufficient short-term assets to cover its liabilities. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) of 9.11% and return on assets (ROA) of 4.86% are below the industry median for medical equipment firms, which typically report ROE in the 12-15% range and ROA in the 6-8% range. This suggests that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in the Taiwan market, where it operates as a primary sales and service provider for medical beauty equipment. No significant international operations are disclosed, and the company does not report revenue by geographic segment beyond its domestic focus. This geographic concentration may expose the company to local economic and regulatory risks. The company's growth trajectory is modest, with no disclosed revenue growth rates or future projections in the provided data. The capital expenditure of -52.15 million TWD indicates a reduction in investment in physical assets, which may reflect a focus on cost control or a shift toward service-based offerings. The company's operating cash flow of 314.86 million TWD and free cash flow of 126.47 million TWD suggest it generates positive cash from operations, but the lack of growth capital spending may limit long-term expansion. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the absence of recent share issuance and the alignment of basic and diluted shares outstanding. However, the negative net cash position after debt is a red flag for liquidity risk, particularly if the company faces unexpected cash outflows. Recent events include the company's latest financial filing, which provides a snapshot of its financial position as of the latest reporting period. No recent earnings call transcripts or material events are disclosed in the input data, limiting visibility into management commentary or strategic shifts.
Key takeaways
  • Dynamic Medical Technologies Inc maintains a conservative capital structure with a low debt-to-equity ratio of 0.24.
  • The company's ROE of 9.11% and ROA of 4.86% are below industry medians, indicating underperformance in capital efficiency.
  • Revenue is concentrated in the Taiwan market, with no disclosed international operations.
  • The company generates positive operating and free cash flows but has reduced capital expenditures, which may limit future growth.
  • Liquidity risk is medium due to a negative net cash position after debt, while dilution risk is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$1.39B
Gross profit$611.4M
Operating income$189.8M
Net income$152.1M
R&D
SG&A
D&A
SBC
Operating cash flow$314.9M
CapEx-$52.2M
Free cash flow$126.5M
Total assets$3.13B
Total liabilities$1.46B
Total equity$1.67B
Cash & equivalents
Long-term debt$404.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1$1.57B$249.3M$205.4M$95.5M
FY-2$1.59B$268.6M$210.3M$220.4M
FY-3$1.29B$158.3M$137.1M$29.6M
FY-4$1.03B$160.4M$123.2M$90.6M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1$3.00B$1.54B$726.3M
FY-2$3.08B$1.54B$924.9M
FY-3$2.68B$1.39B$679.1M
FY-4$2.30B$1.28B$813.4M
PeriodOCFCapExFCFSBC
FY0
FY-1$224.1M-$97.6M$95.5M
FY-2$360.9M-$71.8M$220.4M
FY-3$276.9M-$114.7M$29.6M
FY-4$277.6M-$42.3M$90.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$370.3M$45.8M$36.6M$80.8M
FQ-1$338.0M$45.7M$36.3M$66.8M
FQ-2$327.2M$56.7M$37.6M$69.9M
FQ-3$351.2M$41.6M$41.5M$59.6M
FQ-4$414.7M$76.2M$59.8M$104.5M
FQ-5$356.4M$64.0M$47.7M$64.3M
FQ-6$398.4M$55.1M$49.6M$76.5M
FQ-7$403.2M$54.0M$48.3M$73.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$3.13B$1.67B
FQ-1$2.98B$1.60B
FQ-2$2.86B$1.47B
FQ-3$2.96B$1.42B
FQ-4$3.00B$1.54B$726.3M
FQ-5$2.87B$1.44B$754.9M
FQ-6$2.88B$1.41B$827.1M
FQ-7$3.07B$1.36B$923.4M
PeriodOCFCapExFCFSBC
FQ0$314.9M-$52.2M$80.8M
FQ-1$68.5M-$48.4M$66.8M
FQ-2$30.3M-$36.1M$69.9M
FQ-3-$47.6M-$24.7M$59.6M
FQ-4$224.1M-$97.6M$104.5M
FQ-5$33.9M-$80.5M$64.3M
FQ-6$49.4M-$41.4M$76.5M
FQ-7$27.7M-$20.0M$73.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.67B
Net cash-$404.4M
Current ratio2.2
Debt/Equity0.2
ROA4.9%
ROE9.1%
Cash conversion2.1%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric4138Activity
Op margin13.7%13.3% medp25 5.9% · p75 13.5%top quartile
Net margin11.0%8.6% medp25 2.7% · p75 12.7%above median
Gross margin44.1%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-3.8%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity24.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:02 UTC#50cf31cf
Market quoteclose TWD 56.00 · shares 0.04B diluted
no public URL
2026-05-04 01:01 UTC#149a6fca
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:04 UTCJob: 1cd69f60